Neuromyelitis optica: A clinical update;Neuromielitis óptica: Actualización clínica

Revista de Neurologia

Volumn 51, Issue 5, 2010, Pages 289-294

  Chiquete, Erwin ^a,b   Navarro Bonnet, Jorge ^a   Ayala Armas, Raúl ^c   Gutiérrez Gutiérrez, Noé ^a   Solórzano Meléndez, Alejandro ^a   Rodríguez Tapia, Diana ^d   Gómez Rincón, Marianela ^d   Ruiz Sandoval, José L ^a,b  

^a HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c HOSPITAL GENERAL DE OCCIDENTE   (Mexico)

^d ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

Author keywords

Anti aquaporin 4 antibodies; Demyelination; Devic's disease; Myelitis; Neuromyelitis optica; NMO IgG; Optic neuritis

Indexed keywords

AQUAPORIN 4; AZATHIOPRINE; CORTICOSTEROID; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; RITUXIMAB; AUTOANTIBODY;

DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; OPTIC NERVE; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; REVIEW; SPINAL CORD; TREATMENT DURATION; DEMYELINATING DISEASE; IMMUNOLOGY; PATHOLOGY;

AQUAPORIN 4; AUTOANTIBODIES; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PROGNOSIS;

EID: 77956353420     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5105.2010268     Document Type: Review

References (32)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-15.
2. Pittock SJ. Neuromyelitis optica: a new perspective. Semin Neurol 2008; 28: 95-104.
3. Weinshenker BG, Wingerchuk DM. Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker. Curr Top Microbiol Immunol 2008; 318: 343-56.
4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
5. Sebastián de la Cruz F, López-Dolado E. Neuromielitis óptica de Devic: análisis de siete casos. Rev Neurol 1999; 28: 476-82.
6. Echevarría G, Tróccolli G, D'Annuncio E, Gutiérrez O. Neuromielitis óptica de Devic: forma de presentación como tumor espinal inflamatorio. Rev Neurol 2001; 33: 41-4.
7. Bueno V, Hernández M, Ponce MA, Guerrero AL. Dificultad diagnóstica en una neuromielitis de Devic. Rev Neurol 1999; 28: 341-2.
8. Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 2008; 5: 22.
9. Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F; Spanish-Italian NMO Study Group. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007; 254: 1233-7. (Pubitemid 350112363)
10. Pittock SJ, Lennon VA, De Seze J, Vermersch P, Homburger HA, Wingerchuk DM, et al. Neuromyelitis optica and nonorgan specific autoimmunity. Arch Neurol 2008; 65: 78-83.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
12. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996; 60: 382-7.
13. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003; 60: 848-53.
14. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
15. Ramagopalan SV, Ebers GC. Multiple sclerosis: major histo compatibility complexity and antigen presentation. Genome Med 2009; 1: 105.
16. Bhat R, Steinman L. Innate and adaptive autoimmunity directed to the central nervous system. Neuron 2009; 64: 123-32.
17. Ali EN, Buckle GJ. Neuroimaging in multiple sclerosis. Neurol Clin 2008; 27: 203-19.
18. Gómez-Argüelles JM, Sánchez-Solla A, López-Dolado E, Díez de la Lastra E, Florensa J. Mielitis transversa aguda: revisión clínica y algoritmo de actuación diagnóstica. Rev Neurol 2009; 49: 533-40.
19. Pandit L. Transverse myelitis spectrum disorders. Neurol India 2009; 57: 126-33.
20. Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 2009; 19: 2535-43.
21. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 2007; 68 (Suppl 2): S23-36.
22. Gotkine M, Fellig Y, Abramsky O. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 2006; 67: 881-3. (Pubitemid 44394210)
23. Lehnhardt FG, Scheid C, Holtik U, Burghaus L, Neveling M, Impekoven P, et al. Autologous blood cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus 2006; 15: 240-3.
24. Katramados AM, Rabah R, Adams MD, Huq AHMM, Mitsias PD. Longitudinal myelitis, aseptic meningitis, and conus medullaris infarction as presenting manifestations of pediatric systemic lupus erythematosus. Lupus 2008; 17: 332-6.
25. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, et al. Neuromyelitis optica -IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008; 70: 344-52.
26. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.
27. Okamoto T, Ogawa M, Lin Y, Murata M, Miyake S, Yamamura T. Treatment of neuromyelitis optica: current debate. Ther Adv Neurol Disord 2008; 1: 43-52.
28. Cree B. Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Curr Neurol Neurosci Rep 2008; 8: 427-33.
29. Mangat P, Ravindran J, Cleland L, Limaye V. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica. Clin Rheumatol 2008; 27 (Suppl 2): S67-9.
30. Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 2007; 13: 968-74.
31. Weinstock-Guttman B, Ramanathan M, Lincoff N, Napoli SQ, Sharma J, Feichter J, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 2006; 63: 957-63.
32. Warabi Y, Matsumoto Y, Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2007; 252: 57-61. (Pubitemid 44909191)